03nov2026

Meeting of the board of Directors to approve the consolidated half-yearly financial report as at 30 June 2026

30set2026

Shareholders’ Meeting to approve the Financial Statements as at 31 December 2025.

Shareholders' Meeting to approve the Financial Statements as at 31 December 2025.

31lug2026

Approve (i) the draft financial statements as at 31 December 2025

Approve (i) the draft financial statements as at 31 December 2025

14mar2025

Approval of the draft financial statements as at 31 December 2024 and the consolidated financial statements as at 31 December 2024.

Meeting of the Board of Directors to approve the draft financial statements as at 31 December 2024, and the consolidated financial statements as at 31 December 2024.

22apr2025

Annual Shareholders’ Meeting

Shareholders' Meeting to approve the Financial Statements as at 31 December 2024.

12mag2025

Quarterly financial report as at 31/03/2025

Meeting of the Board of Directors to approve the consolidated quarterly financial report as at 31/03/2025

08ago2025

Half-yearly financial report as at 30/06/2025.

Meeting of the Board of Directors to approve the consolidated half-yearly financial report as at 30/06/2025.

12nov2025

Quarterly financial report as at 30/09/2025

Meeting of the Board of Directors to approve the consolidated financial report as at 30/09/2025

06feb2024

Preliminary Results as of 31 December 2023

Board of Directors meeting to approve the preliminary results as of December 31st, 2023.

07feb2024

Capital Markets Day

Capital Markets Day

21mar2024

Approval of the Draft Financial Statements as of 31 December 2023

Board of Directors meeting to approve the Consolidated Financial Statements as of December 31st, 2023 and the draft of the Annual Report as of December 31st, 2023.

29apr2024

Annual Shareholders’ Meeting

Shareholders’ Meeting to approve the Company’s financial statements as of December 31st, 2023.

15mag2024

Quarterly Report as of 31 March 2024

Board of Directors meeting to approve selected information related to business performance for the first quarter of 2024(*) (Revenues; EBITDA; Backlog; Net Financial Position) and related press release containing quarterly information. (*) Information not subject to audit, not even limited.

10set2024

Half-Yearly Report as of 30 June 2024

Board of Directors meeting to approve the Consolidated half-yearly Financial Report as of June 30th, 2024.

12nov2024

Quarterly Report as of 30 September 2024

Board of Directors meeting to approve indicative selected information related to business performance for the third quarter of 2024(*) (Revenues; EBITDA; Backlog; Net Financial Position) and related press release containing quarterly information. (*) Information not subject to audit, not even limited.

24gen2023

Preliminary Financial Results as at 31 December 2022 and Capital Markets Day

Board of Directors Meeting to approve preliminary results as at 31 December 2022; Capital Markets Day – strategy update and economic and financial outlook.

21mar2023

Approval of the Draft Financial Report as at 31 December 2022

Meeting of the Board of Directors to approve the draft Financial Report as at 31 December 2022.

27apr2023

Ordinary Shareholders’ Meeting

Shareholders’ Meeting to approve the Financial Report as at 31 December 2022.

10mag2023

Quarterly Report as at 31 March 2023

Board of Directors Meeting to approve the selected information indicative of the business performance for the first quarter of 2023(*)(Revenues; EBITDA; Backlog; Net Financial Position) and the related press release including the quarterly information. (*) Information not subject to audit, not even limited.

07set2023

Half-Year Report as at 30 June 2023

Board of Directors Meeting to approve the Half-Year Financial Report as at 30 June 2023.

07nov2023

Quarterly Report as at 30 September 2023

• Board of Directors Meeting to approve the selected information indicative of the business performance for the third quarter of 2023(*)(Revenues; EBITDA; Backlog; Net Financial Position) and the related press release including the quarterly information. (*) Information not subject to audit, not even limited.

24mar2022

Approval of the Draft Financial Statements at December 31st 2021

Meeting of the Board of Directors to approve the draft Financial Statements at December 31st, 2021.

29apr2022

Shareholders’ Meeting

Shareholders' Meeting to approve the Financial Statements at December 31st , 2021

11mag2022

Quarterly Report at March 31st, 2022

Meeting of the Board of Directors to approve the selected information indicative of the performance of the business for the first quarter of 2022(*) (Production value; EBITDA; Backlog; Net Financial Position) and the related press release containing the quarterly information. (*) Information not subject to revision, not even limited

04ago2022

Preliminary financial data as at June 30th, 2022

Meeting of the Board of Directors for approval of preliminary financial data at June 30th, 2022.

22feb2022

Preliminary financial data as at December 31st, 2021 and Guidance 2022

Meeting of the Board of Directors for approval of preliminary financial data as at December 31st, 2021 and Guidance 2022.

13set2022

Half-Year Financial Statements at June 30th, 2022

Board of Directors for the approval of Half-Year Financial Statements at June 30th, 2022.

10nov2022

Quarterly Report at September 30th, 2022

Meeting of the Board of Directors to approve the selected information indicative of the performance of the business for the third quarter of 2022(*) (Production value; EBITDA; Backlog; Net Financial Position) and the related press release containing the quarterly information. (*) Information not subject to revision, not even limited.

15set2021

Half-Year Financial Statements at June 30th, 2021

Board of Directors for the approval of Half-Year Financial Statements at June 30th, 2021.

15nov2021

Quarterly Report at September 30th, 2021

Board of Directors for the approval of the press release containing a quarterly reporting with selected information reflective of the development of the business related to the third quarter of 2021(*) (Production Value; EBITDA; Backlog; Net Financial Position). (*) Information not subject to revision, not even limited.